ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,907Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 944

$707K Total Retail Price of All Prescriptions

Rank: 65 out of 944

415 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 415 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 415 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,773 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 474 359 1 5
SIMVASTATIN 458 345 2 1
LISINOPRIL 367 277 3 3
LEVOTHYROXINE SODIUM 337 266 4 2
OMEPRAZOLE 337 256 4 4
FUROSEMIDE 302 225 6 6
METFORMIN HCL 296 214 7 12
METOPROLOL TARTRATE 275 196 8 8
HYDROCODONE-ACETAMINOPHEN 249 197 S3 9 10
ATORVASTATIN CALCIUM 208 184 10 13
PRAVASTATIN SODIUM 203 166 11 17
ZOLPIDEM TARTRATE 202 136 12 25
WARFARIN SODIUM 182 163 13 7
CLOPIDOGREL 174 140 14 36
ALLOPURINOL 165 148 15 22
TRAMADOL HCL 163 102 16 21
LOSARTAN POTASSIUM 159 106 17 16
MIRTAZAPINE 152 144 18 35
CARVEDILOL 139 119 19 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 119 20 29
POTASSIUM CHLORIDE 134 124 21 15
NEXIUM 129 88 22 53
PANTOPRAZOLE SODIUM 129 95 22 34
PLAVIX 120 106 24 55
ATENOLOL 119 103 25 11
GABAPENTIN 115 57 26 18
MELOXICAM 114 78 27 68
GLIMEPIRIDE 112 81 28 47
CYCLOBENZAPRINE HCL 108 33 R 29 86
CRESTOR 104 82 30 28
AZITHROMYCIN 100 76 31 70
CITALOPRAM HBR 98 62 32 19
DONEPEZIL HCL 98 88 32 24
ADVAIR DISKUS 90 43 34 31
RANITIDINE HCL 90 39 34 42
HYDROCHLOROTHIAZIDE 90 75 34 9
PREDNISONE 82 69 37 32
DIGOXIN 74 61 38 39
ACETAMINOPHEN-CODEINE 71 60 S3 39 95
LOSARTAN-HYDROCHLOROTHIAZIDE 68 67 40 54
PEN NEEDLE 68 39 40 100
IBUPROFEN 63 29 42 140
TAMSULOSIN HCL 62 53 43 27
OXYCODONE-ACETAMINOPHEN 61 45 S2 44 62
FAMOTIDINE 61 44 44 74
DOXAZOSIN MESYLATE 60 49 46 60
METOPROLOL SUCCINATE 59 46 47 14
CIPROFLOXACIN HCL 57 52 48 90
TOPIRAMATE 56 11 49 189
METOCLOPRAMIDE HCL 56 45 49 146
TRICOR 55 0 51 158
ESCITALOPRAM OXALATE 54 53 52 98
ISOSORBIDE MONONITRATE ER 53 41 53 52
KLOR-CON M20 53 39 53 71
TRIAMTERENE-HCTZ 52 35 55 33
ZETIA 50 27 56 59
LIPITOR 50 47 56 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.